Global CDMO market expected to reach $191.6 billion by 2029 with 7.0% CAGR growth

From GlobeNewswire: 2025-01-30 09:36:00

The global market for Contract Development and Manufacturing Organizations (CDMO) was valued at $128.0 billion in 2023, expected to reach $191.6 billion by 2029 with a 7.0% CAGR. The industry covers API manufacturing, drug production, and regulatory support, with major players making strategic moves to capitalize on market growth.

Factors driving the growth of the CDMO market include a surge in clinical trials, increased R&D spending, rising demand for advanced therapeutics, and pharmaceutical outsourcing. The market is segmented by service type, molecule, end user, and region, with drug product manufacturing expected to dominate in 2029, led by North America.

Top companies in the CDMO market include Boehringer Ingelheim, Catalent, Lonza, and Samsung Biologics. Related reports cover Contract Research Organization (CRO) services and Contract Pharmaceutical Manufacturing, Research, and Packaging, highlighting the importance of outsourcing in the pharmaceutical industry for cost savings and efficiency.

For more information on the CDMO market and related reports, contact [email protected]. BCC Research provides unbiased market analysis to help businesses make informed decisions in a noisy market landscape.



Read more at GlobeNewswire: Global CDMO Market Set for 7.0% CAGR Growth, Surpassing